ACP Journal Club. Review: sodium-glucose cotransporter 2 inhibitors reduce HbA1c and weight but increase infections
- PMID: 24445708
- DOI: 10.7326/0003-4819-160-2-201401210-02010
ACP Journal Club. Review: sodium-glucose cotransporter 2 inhibitors reduce HbA1c and weight but increase infections
Comment on
-
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.Ann Intern Med. 2013 Aug 20;159(4):262-74. doi: 10.7326/0003-4819-159-4-201308200-00007. Ann Intern Med. 2013. PMID: 24026259
Similar articles
-
Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Overview of the Efficacy and Safety of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus.J Fam Pract. 2017 Feb;66(2 Suppl):S5-S12. J Fam Pract. 2017. PMID: 28222460 Review.
-
Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Role of the Kidney in Glucose Homeostasis: Implications for SGLT-2 Inhibition in the Treatment of Type 2 Diabetes Mellitus.J Fam Pract. 2017 Feb;66(2 Suppl):S3-S5. J Fam Pract. 2017. PMID: 28222459
-
Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus.J Fam Pract. 2017 Feb;66(2 Suppl):S13-S16. J Fam Pract. 2017. PMID: 28222461
-
Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes.Curr Med Res Opin. 2016 Jun;32(6):1097-108. doi: 10.1185/03007995.2016.1161608. Epub 2016 Apr 4. Curr Med Res Opin. 2016. PMID: 26933918
-
The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes.Can J Diabetes. 2017 Oct;41(5):517-523. doi: 10.1016/j.jcjd.2017.08.241. Can J Diabetes. 2017. PMID: 28942789 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical